All the negativity on here makes me thinks that it might be time to buy again....
Lots of good news recently,
60+ patients when last update we got was 50....
NASDAQ listing getting closer (which I will assume will come with a very decent cash injection)
And also excellent results in the first Valve in Valve in Valve case I've ever read about. I have researched on the internet and also asked industry insiders if there has ever been a ViViV case that they know about and they say no although it is possible.... but if so they are unaware of one.
And our valve got better results than the original SAVR. Remarkable.
Partnership or corporate action could come at anytime.... we know that Johnson&Johnson have a recent history of significant action in the cardiac space. We know also that Medtronic could view acquiring or partnering with DurAVR could mean that they take over as market leader from Edwards. We know that Edwards must see us as a serious threat to their companies TAVR division and this could incentivise them to buy or partner with us..... all interesting scenarios which could see significant corporate action.
We will see.
AVR Price at posting:
$20.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)